CDMRP Neurotoxin Exposure Treatment Parkinson’s Program: Investigator-Initiated Research Award

The NETP Program invests in scientific research to better understand and treat the neuro-degenerative effects of PD.

Investigators must address at least one of the following Focus Areas:

• Quantifiable gene - environment interactions and the risk for or progression of Parkinson’s disease following neurotoxin exposure.
• Basic biology of non-motor symptoms that could lead to the development of new treatments for Parkinson’s disease following neurotoxin exposure.
• System-level mechanism of dopamine refractory motor symptoms in Parkinson’s disease that could lead to development of new treatments in patients with neurotoxin exposure.
• Clinical and research application of digital health technology leading to development of new treatments for Parkinson’s disease in those individuals exposed to neurotoxins.

Funding: $1,200,000 total

Duration: 3 years 

Research Authority due date: 11.8.20

Pre application (required) due date: 18.8.20

Full proposal due date: 16.9.20